Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

NCT03961945 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03961945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03961945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2021
Completion date
November 25, 2025
Enrollment
1,526 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal adenocarcinoma